/IMMG

IMMG Stock - Immage Biotherapeutics Corp.

Q: What is the analyst price target for IMMG?

Analyst price target information is not currently available for IMMG.

Q: What is IMMG's market cap?

Market capitalization information is not currently available for IMMG.

Financial Services|Financial - Conglomerates|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for IMMG

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2012

FY2013

FY2014

FY2015

FY2016

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta32.51

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2016	FY2015	FY2014	FY2013	FY2012
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	$-8,528	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-216,476	$-58.766	$-18,555	$-12,011	$-7.684
Net Income	$-216,476	$-58.766	$-18,555	$-12,011	$-7.684
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.00	$-0.00	$-0.03	$-0.01	$-0.00

Company Overview

Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.

Visit Website

Frequently Asked Questions about IMMG

What is IMMG's current stock price?

Immage Biotherapeutics Corp. (IMMG) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for IMMG?

No analyst price targets are currently available for this stock.

What sector is Immage Biotherapeutics Corp. in?

Immage Biotherapeutics Corp. operates in the Financial Services sector, specifically within the Financial - Conglomerates industry. The company is traded on the OTC exchange.

What is IMMG's market cap?

Immage Biotherapeutics Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does IMMG pay dividends?

No, Immage Biotherapeutics Corp. does not currently pay a dividend to shareholders.